August 25, 2011 — Bayer HealthCare Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its investigational compound, radium-223 chloride, exclusively licensed from Algeta ASA. The compound is for the treatment of castration-resistant (hormone-refractory) prostate cancer in patients with bone metastases.

August 25, 2011 — MedQuist Holdings Inc., provider of integrated clinical documentation solutions for the United States healthcare system, announced it has closed on the acquisition of M*Modal. The closing price included $48.4 million in cash and the issuance of 4.1 million shares of MedQuist Holdings common stock paid at closing. The company received notification of early termination of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 on Aug. 15.

August 24, 2011 – Only a few years after its introduction at the Radiological Society of North America (RSNA)’s annual meeting in late 2007, Philips Brilliance iCT scanners have been installed around the world, including Shandong Tumor Hospital & Institutein Jinan, Shandong Province, a top oncology hospitals in China. Shandong Tumor Hospital and Institute recently marked a milestone by receiving the 300th shipment.

August 24, 2011 – RaySearch Laboratories has received an order for its RayStation treatment planning system from Health Quest Systems Inc., headquartered in LaGrange, N.Y.

August 23, 2011– Claron Technology, the Toronto-based medical imaging software innovator, has received International Organization for Standardization (ISO) certification in three categories for its quality management system. From its recently introduced Nil zero-footprint Web-based digital imaging and communications in medicine (DICOM) viewer to its ClaroNav surgical-guidance-by-video platform and versatile Withinsight Framework (WIF) advanced visualization software framework, Claron’s advanced technology has established the company as an industry innovator since its inception in 2001.

August 23, 2011— UltraSPECT of Haifa, Israel, announced the sale of more than 10 of its wide beam reconstruction (WBR) software solutions to nuclear pharmaceutical supplier PCI for placement at customer medical facilities throughout Arizona. PCI is a member of United Pharmacy Partners Inc. (UPPI), a nuclear pharmacy network consortium that recently signed a multi-year distribution agreement for the leasing and/or non-exclusive sales of UltraSPECT’s cardiac and bone imaging applications in the United States.

August 22, 2011 – Devicor Medical Products Inc. announced the completion of its previously discussed agreement to acquire the neoprobe gamma detection system (GDS) products and related assets from Neoprobe Corporation.

August 19, 2011 – Matrox confirmed that professional-grade monitor manufacturer Eizo Nanao Corporation is offering the Matrox Xenia Pro for use with its latest high-resolution Eizo FDH 8MP medical display.

August 19, 2011 – Cell Therapeutics Inc. announced that enrollment has opened for a randomized phase II clinical study comparing the combination of Opaxio (paclitaxel poliglumex, PPX) and radiation to the combination of temozolomide (TMZ) and radiation for patients with newly diagnosed glioblastoma, a high-grade malignant brain tumor.